Cash & equivalents increased 179.7%
Cash & equivalents changed +179.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +179.7% from the comparable as-filed period.
Gross margin changed +3002 basis points from the comparable as-filed period.
Gross profit changed +1539.1% from the comparable as-filed period.
Operating margin changed +376029 basis points from the comparable as-filed period.
Research & development changed -29.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed +547.6% from the comparable as-filed period.
Stock-based compensation changed -99.3% from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes.
Net income changed +5.3% from the comparable as-filed period.
Operating income changed +3.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.